These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26201468)

  • 1. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
    Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM
    Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidic fibroblast growth factor (FGF-1) and FGF receptor 1 signaling in human Y79 retinoblastoma.
    Siffroi-Fernandez S; Cinaroglu A; Fuhrmann-Panfalone V; Normand G; Bugra K; Sahel J; Hicks D
    Arch Ophthalmol; 2005 Mar; 123(3):368-76. PubMed ID: 15767480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1.
    Ren M; Hong M; Liu G; Wang H; Patel V; Biddinger P; Silva J; Cowell J; Hao Z
    Oncol Rep; 2013 Jun; 29(6):2181-90. PubMed ID: 23563700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer.
    Xu C; Li W; Qiu P; Xia Y; Du X; Wang F; Shen L; Chen Q; Zhao Y; Jin R; Wu J; Liang G; Li X
    Anticancer Drugs; 2015 Apr; 26(4):379-87. PubMed ID: 25521558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells.
    Lefèvre G; Babchia N; Calipel A; Mouriaux F; Faussat AM; Mrzyk S; Mascarelli F
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1047-57. PubMed ID: 19029025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.
    Hu Y; Guimond SE; Travers P; Cadman S; Hohenester E; Turnbull JE; Kim SH; Bouloux PM
    J Biol Chem; 2009 Oct; 284(43):29905-20. PubMed ID: 19696444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
    Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
    Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
    André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
    Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
    Peng X; Hou P; Chen Y; Dai Y; Ji Y; Shen Y; Su Y; Liu B; Wang Y; Sun D; Jiang Y; Zha C; Xie Z; Ding J; Geng M; Ai J
    J Exp Clin Cancer Res; 2019 Aug; 38(1):372. PubMed ID: 31438996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine and human sarcomas exhibit predominant FGFR1 expression and impaired viability after inhibition of signaling.
    Schweiger N; Hauck M; Steinhoff H; Sampl S; Reifinger M; Walter I; Kreilmeier T; Marian B; Grusch M; Berger W; Holzmann K; Kleiter M
    Mol Carcinog; 2015 Sep; 54(9):841-52. PubMed ID: 24719266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer.
    Tomlinson DC; Lamont FR; Shnyder SD; Knowles MA
    Cancer Res; 2009 Jun; 69(11):4613-20. PubMed ID: 19458078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer.
    Adachi Y; Watanabe K; Kita K; Kitai H; Kotani H; Sato Y; Inase N; Yano S; Ebi H
    Carcinogenesis; 2017 Oct; 38(11):1063-1072. PubMed ID: 28968756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel FGFR1-binding peptide exhibits anti-tumor effect on lung cancer by inhibiting proliferation and angiogenesis.
    Tan Q; Wang Z; Wang Q; Wang Y; Huang Z; Su N; Jin M; Kuang L; Qi H; Ni Z; Li C; Zhu Y; Jiang W; Chen H; Deng C; Du X; Xie Y; Chen L
    Int J Biol Sci; 2018; 14(10):1389-1398. PubMed ID: 30123084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Chen B; Liu S; Gan L; Wang J; Hu B; Xu H; Tong R; Yang H; Cristina I; Xue J; Hu X; Lu Y
    Cancer Biol Ther; 2018 Jan; 19(1):76-86. PubMed ID: 29257923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. Implications for dynamic assembly of a ternary signaling complex.
    Powell AK; Fernig DG; Turnbull JE
    J Biol Chem; 2002 Aug; 277(32):28554-63. PubMed ID: 12034712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity.
    Opaliński Ł; Sokołowska-Wędzina A; Szczepara M; Zakrzewska M; Otlewski J
    Sci Rep; 2017 Aug; 7(1):7121. PubMed ID: 28769084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR1 is an independent prognostic factor and can be regulated by miR-497 in gastric cancer progression.
    Xie G; Ke Q; Ji YZ; Wang AQ; Jing M; Zou LL
    Braz J Med Biol Res; 2018 Nov; 52(1):e7816. PubMed ID: 30484492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.